Mechanism of action, clinical indication, adverse reactions
2. Reduces excitatory neurotransmitter release (i.e., glutamate) via presynaptic and postsynaptic alpha-2 receptor stimulation in the spinal cord (inhibits intracellular Ca)
3. Reduces muscle spasticity associated with cerebral and spinal disorders
4. Adverse reactions - dry mouth, drowsiness, asthenia (muscle weakness), hypotension